Mr. Stephen M. Casey This is Me

Education

 View all 11 references Web References

1. 1. Colon Cancer Alliance - CCA Organization - Strategic Advisory Board

   www.ccalliance.org/cca/org/str - [Cached]

   Published on: 1/16/2000   Last Visited: 3/5/2003

   Stephen M. Casey, is the Vice President of Sales and Marketing for InKine Pharmaceutical Co., Inc., a specialty pharmaceuticalcompany with a biotech pipeline. Previously Mr. Casey was the Managing Director of Axcan Schwarz LLC, a joint venture company between Axcan Pharma of Canada and Schwarz Pharma of the U.S. Mr. Casey has held a variety of marketing, sales and business development positions including General Manager of Kremers Urban, a division of Schwarz Pharma, and gastrointestinal product group manager for Schwarz Pharma. While working in pharmaceutical marketing and sales, Mr. Casey has actively developed strong relationships with the Pharmaceutical Care Management Association (PCMA) and the American Liver Foundation (ALF).

2. 2. InKine Pharmaceutical Annual Report 2000

   www.inkine.com/2000report/2000 - [Cached]

   Published on: 3/8/2003   Last Visited: 3/8/2003

   Stephen M. Casey, M.B.A., Vice President of Sales & Marketing
   
   Stephen Casey brings extensive experience in gastrointestinal marketing and sales to his role at InKine, where he is responsible for overseeing and implementing our commercial strategy. Mr. Casey came to us from Axcan Schwarz LLC, a joint venture company where he served as Director of Management. Prior to that, he held positions of increasing responsibility at Schwarz Pharma Inc., beginning in 1988. His achievements there involved managing several launches, including URSO® (ursodiol tablets), Levbid® (hyoscyamine sulfate), Edex® (alprostadil), and the re-introduction of Colyte® (PEG3350 & electrolytes), CortiFoam® (hydrocortisone 10%) and the Procto® products (hydrocortisone 1% & pramoxine 1%). Mr. Casey holds an M.B.A. in International Business and Marketing from the University of Connecticut.

3. 3. Todays News

   www.prnewswire.com/cgi-bin/sto - [Cached]

   Published on: 10/3/2000   Last Visited: 10/3/2000

   Stephen Casey, Vice President of Sales & Marketing for InKine, today lauded the NCCRA for its proven track record of increasing patient and physician awareness of colon cancer screening and the value of early detection. InKine's long term partnership with the NCCRA will benefit colon cancer patients while enhancing the company's long term goals of improving patient lives and increasing the diagnosis and treatment of colon cancer, the second-leading cancer killer in the United States..
   
   InKine Pharmaceutical Company, Inc. is a publicly-traded biopharmaceutical company focused on the diagnosis and treatment of cancer and autoimmune diseases. The company's development strategy is to acquire late-stage drug candidates with short time lines to commercialization. Support of early-stage product opportunities comes through university-based sponsored research.